Arcturus Therapeutics Lands $5,924,599 New Financing

  • Feed Type
  • Date
  • Company Name
    Arcturus Therapeutics
  • Mailing Address
    3210 Merryfield Row San Diego, CA 92121 USA
  • Company Description
    Arcturus Therapeutics is poised to become an industry leader in the application of RNAi technologies for the treatment of disease and improved quality of life. The company’s aim is to develop breakthrough technology and novel therapeutics for rare diseases for which there is no adequate treatment.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt.
  • M&A Terms
  • Venture Investor

Trending on Xconomy